- We will send in 10–14 business days.
/images/books/3070029/9780323907736.jpg)
- Publisher: Elsevier
- ISBN-10: 0323907733
- ISBN-13: 9780323907736
- Format: 19.1 x 23.5 x 4.3 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Nanocarriers for Drug-Targeting Brain Tumors (e-book) (used book) | bookbook.eu
Reviews
Description
Nanocarriers for Drug-Targeting Brain Tumors covers different types of nanocarriers and their design and development for targeting drugs to the brain. The book also presents case studies and the mechanism of action of nanocarriers in drug targeting to a specific site. This helps researchers and clinicians understand the design, development and mechanism of action of nanocarriers. As brain tumors continue to be a significant health problem globally, and very complex for targeting drugs, conventional dosage forms are not very effective and side-effects are a major concern. Functionalized nanocarriers can address these problems.
Furthermore, the targeting of nanocarriers is preferred for reducing toxicity and improving the effectiveness of the drugs. However, there is a need for understanding the design and development of formulation with the mechanism of action of nanocarriers for brain targeting.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 14d.18:14:58
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Elsevier
- ISBN-10: 0323907733
- ISBN-13: 9780323907736
- Format: 19.1 x 23.5 x 4.3 cm, softcover
- Language: English English
Nanocarriers for Drug-Targeting Brain Tumors covers different types of nanocarriers and their design and development for targeting drugs to the brain. The book also presents case studies and the mechanism of action of nanocarriers in drug targeting to a specific site. This helps researchers and clinicians understand the design, development and mechanism of action of nanocarriers. As brain tumors continue to be a significant health problem globally, and very complex for targeting drugs, conventional dosage forms are not very effective and side-effects are a major concern. Functionalized nanocarriers can address these problems.
Furthermore, the targeting of nanocarriers is preferred for reducing toxicity and improving the effectiveness of the drugs. However, there is a need for understanding the design and development of formulation with the mechanism of action of nanocarriers for brain targeting.
Reviews